The coordinated regulation of mitochondrial and nuclear activities is essential for cellular respiration and its disruption leads to mitochondrial dysfunction, a hallmark of ageing. Mitochondria communicate with nuclei through retrograde signalling pathways that modulate nuclear gene expression to maintain mitochondrial homeostasis. The monooxygenase CLK-1 (human homologue COQ7) was previously reported to be mitochondrial, with a role in respiration and longevity. We have uncovered a distinct nuclear form of CLK-1 that independently regulates lifespan. Nuclear CLK-1 mediates a retrograde signalling pathway that is conserved from Caenorhabditis elegans to humans and is responsive to mitochondrial reactive oxygen species, thus acting as a barometer of oxidative metabolism. We show that, through modulation of gene expression, the pathway regulates both mitochondrial reactive oxygen species metabolism and the mitochondrial unfolded protein response. Our results demonstrate that a respiratory enzyme acts in the nucleus to control mitochondrial stress responses and longevity.
A nuclear role for the respiratory enzyme CLK-1 in regulating mitochondrial stress responses and longevity Richard M. Monaghan 1 , Robert G. Barnes 1 , Kate Fisher 1 , Tereza Andreou 1,2 , Nicholas Rooney 1,2 , Gino B. Poulin 1,3 and Alan J. Whitmarsh 1, 3 The coordinated regulation of mitochondrial and nuclear activities is essential for cellular respiration and its disruption leads to mitochondrial dysfunction, a hallmark of ageing. Mitochondria communicate with nuclei through retrograde signalling pathways that modulate nuclear gene expression to maintain mitochondrial homeostasis. The monooxygenase CLK-1 (human homologue COQ7) was previously reported to be mitochondrial, with a role in respiration and longevity. We have uncovered a distinct nuclear form of CLK-1 that independently regulates lifespan. Nuclear CLK-1 mediates a retrograde signalling pathway that is conserved from Caenorhabditis elegans to humans and is responsive to mitochondrial reactive oxygen species, thus acting as a barometer of oxidative metabolism. We show that, through modulation of gene expression, the pathway regulates both mitochondrial reactive oxygen species metabolism and the mitochondrial unfolded protein response. Our results demonstrate that a respiratory enzyme acts in the nucleus to control mitochondrial stress responses and longevity.
Mitochondria function as cellular energy generators producing the fuel, predominantly in the form of adenosine triphosphate (ATP), required to drive biological processes. They act as a hub for many essential biochemical pathways, the metabolites of which are closely monitored by the cell [1] [2] [3] . Most of the enzymes that are required for these pathways are encoded by the nuclear genome compared with a few that are encoded directly by the mitochondrial genome. Therefore, coordinated regulation of nuclear and mitochondrial gene expression is essential 4, 5 . Mitochondrial activity is monitored through a variety of mitochondrial readouts that include the amount of reactive oxygen species (ROS) produced during oxidative metabolism, the rate of ATP production, and the level of misfolded proteins. These readouts activate or inhibit cytosolic signalling pathways that ensure the appropriate changes in nuclear gene expression occur to maintain mitochondrial homeostasis [2] [3] [4] [5] [6] .
Mitochondrial dysfunction is a hallmark of ageing and alterations in mitochondrial activity affect the lifespan of model organisms 7, 8 . Indeed, increased mitochondrial ROS modulates stress responses and promotes longevity 3, [8] [9] [10] . In addition, the initiation of a distinct mitochondrial to nuclear retrograde signalling pathway, the mitochondrial unfolded protein response (UPR mt ), has been proposed to extend lifespan [11] [12] [13] . These findings suggest a direct link between mitochondrial stress and longevity.
In Caenorhabditis elegans, mutants of components of the electron transport chain exhibit reduced oxidative phosphorylation and increased longevity 14 . The mitochondrial diiron-containing monooxygenase CLK-1 catalyses the hydroxylation of 5-demethoxyubiquinone, a critical step in the biosynthesis of ubiquinone, an essential cofactor of the electron transport chain 15, 16 . However, C. elegans clk-1 null mutants and heterozygous mice exhibit altered mitochondrial metabolism and extended lifespans through a pathway that seems to be independent of ubiquinone biosynthesis and ATP production [17] [18] [19] [20] [21] . This indicates that additional functions for CLK-1 may exist. CLK-1, and its human homologue COQ7, contain an amino-terminal mitochondrial targeting sequence (MTS) and are assumed to reside exclusively within mitochondria 22, 23 . However, we have observed CLK-1 and COQ7 present in the nuclei of C. elegans and cultured human cells, respectively. Furthermore, we have uncovered a specific role for the nuclear pools of CLK-1 and COQ7 in the regulation of ROS metabolism, mitochondrial stress responses and longevity. 
RESULTS

CLK-1 and its human homologue COQ7 localize to mitochondria and nuclei
We found that endogenous and exogenously expressed COQ7 exhibit both mitochondrial and nuclear immunostaining in HeLa cells (Fig. 1a,b and Supplementary Fig. 1a ). Consistent with this, adult transgenic worms expressing CLK-1 fused to green fluorescent protein (GFP) also exhibit fluorescence in both compartments ( Fig. 1c ). We identified a sequence in COQ7 between amino acids 11 and 29 that is required for nuclear localization ( Supplementary Fig. 1b ). This nuclear targeting sequence (NTS) is adjacent to the MTS, but within the Nterminal region that is cleaved and degraded by the mitochondrial processing peptidase (MPP) following mitochondrial import 23 (Fig. 2b ). This suggested that a pool of COQ7, rather than being imported into Fig. 2f ). Unprocessed original scans of immunoblots are shown in Supplementary Fig. 5 .
mitochondria and cleaved, remains uncleaved and localizes to the nucleus. This scenario is supported by nuclear-specific immunostaining of endogenous COQ7 with antibodies that specifically recognize the N-terminal region ( Fig. 1d and Supplementary Fig. 1c ). It was also observed that two forms of COQ7 were visible on immunoblots of cell lysates and that both were decreased by COQ7 -specific short interfering RNA (siRNA; Fig. 1e ). These corresponded to the uncleaved and cleaved forms of the protein ( Supplementary Fig. 1d ). Taken together, these data establish that distinct mitochondrial and nuclear forms of COQ7 coexist within cells. This dual localization of CLK-1 and COQ7 suggests that they may be part of a regulatory mechanism that links mitochondrial function Figure 3 A truncated form of C. elegans CLK-1 with impaired mitochondrial targeting is predominantly nuclear and does not rescue ubiquinone biosynthesis. (a) The mechanism of targeting of C. elegans CLK-1 and human COQ7 to nuclei is not conserved. Alignment of the N termini and the start of the highly conserved diiron-binding domains of CLK-1 and COQ7. The mitochondrial targeting sequence (MTS) is denoted by the black bars, conserved amino acids are highlighted in blue, and the predicted mitochondrial processing peptidase (MPP) site in COQ7 is shown. The region in COQ7 containing determinants of nuclear localization (NTS) is denoted by the red bar and residues required for nuclear targeting are highlighted in red. CE, C. elegans; HS, Homo sapiens. The numbers refer to aminoacid positions. (b) CLK-1 lacking the MTS (CLK-1 nuc(+) ) is predominantly nuclear in adult worms. Arrows mark nuclei. MT, MitoTracker (mitochondrial marker). (c) CLK-1 nuc(+) expression does not rescue the loss of mitochondrial ubiquinone (UQ9) biosynthesis in clk-1(−) worms. Reverse-phase HPLC chromatograms of quinones extracted from the indicated strains (UQ9 peak at 8.78 min, DMQ9 peak at 8.42 min). CLK-1 wt but not CLK-1 nuc(+) restores the UQ9 peak lost in clk-1 (clk-1(−)) null worms.
to nuclear events. It has been proposed that the regulation of mitochondrial protein import in response to changes in ROS production and peptide efflux can act as a gauge of mitochondrial activity and dysfunction 11, 24 . We found that the exposure of cells to an antioxidant (N -acetyl-L-cysteine; NAC) decreased the amount of nuclear COQ7 (Fig. 1f ). The same treatment in worms reduced CLK-1-GFP nuclear localization ( Fig. 1g ). Conversely, an increase in ROS enhanced nuclear COQ7 levels ( Fig. 1f ) and this correlated with an increase in the amount of uncleaved COQ7 (Fig. 1h ). To provide evidence that ROS regulation of mitochondrial import of COQ7 was a key determinant of its nuclear localization, we engineered a mutant with impaired mitochondrial targeting (COQ7 R11/14/16D). The mutant remained uncleaved and predominantly localized to nuclei, independently of ROS levels (Fig. 1i ,j and Supplementary Fig. 1e ). These data are consistent with a model in which a distinct pool of uncleaved COQ7 is targeted to the nucleus following inhibition of mitochondrial import through a ROS-dependent pathway.
Nuclear COQ7 functions independently of the mitochondrial form
To further characterize the nuclear targeting of COQ7, we performed site-directed mutagenesis of conserved residues within the N-terminal NTS ( Supplementary Fig. 2a ). We identified a point mutant (R28A) that, compared with wild-type COQ7, exhibited significantly reduced nuclear localization ( Fig. 2a and Supplementary Fig. 2b ). Furthermore, by inserting an epitope tag (OLLAS) immediately carboxy-terminal to the NTS but before the MPP cleavage site, we demonstrated that uncleaved wild-type COQ7 is present in nuclei but the R28A mutant is not ( Fig. 2b,c ). This is supported by immunoblots of cell lysates showing decreased amounts of uncleaved R28A mutant protein compared with the wild-type protein ( Supplementary Fig. 2c ). These data suggest that a pool of COQ7 can be redirected to the nucleus whereas the R28A mutant is predominantly targeted to mitochondria where it is cleaved.
As the loss of COQ7 expression would affect both its mitochondrial and nuclear functions, we created a system to specifically determine the effect of depleting nuclear COQ7. Cell lines were established with endogenous COQ7 expression replaced by ectopic expression of either wild-type COQ7 or the non-nuclear R28A mutant ( Fig. 2d and Supplementary Fig. 2d ). As expected, uncleaved wild-type COQ7 resided in the nuclear fraction but the uncleaved form was absent in the R28A-expressing cells ( Fig. 2e ). Importantly, both cell lines had normal levels of ubiquinone ( Fig. 2f and Supplementary Fig. 2e ). The loss of nuclear COQ7 resulted in a decreased cell count that, in the absence of an increase in cell death, was indicative of impaired proliferation ( Fig. 2g and Supplementary Fig. 2f ). These data demonstrate that COQ7 has a biologically relevant nuclear role that is independent of its characterized mitochondrial function in ubiquinone biosynthesis.
A truncated form of C. elegans CLK-1 with impaired mitochondrial targeting is predominantly nuclear and does not rescue ubiquinone biosynthesis
The N termini of C. elegans CLK-1 and human COQ7 are not well conserved compared with the high conservation of their diironbinding domains that are C-terminal to their predicted MPP cleavage sites ( Fig. 3a) . Indeed, the N-terminal residues we identified as being critical for nuclear localization of COQ7 do not seem to be conserved in CLK-1. However, both homologues localize to the nucleus in a ROS-dependent manner (Fig. 1 ). This suggests that, although their nuclear role may be conserved, the precise molecular mechanism by which they are targeted to nuclei may be distinct. To address the nonmitochondrial function of worm CLK-1, we generated a transgenic animal featuring a single copy insertion expressing CLK-1 with the predicted 13-residue MTS deleted and GFP fused at its C terminus. This protein localized predominantly to the nucleus, demonstrating that, similar to COQ7, when mitochondrial targeting is impaired, nuclear localization is prevalent ( Fig. 3b ). We next crossed transgenic worms expressing either full-length CLK-1 (clk-1 wt ) or this truncated nuclear-only form of CLK-1 (clk-1 nuc(+) ) with the clk-1 null worm qm30 (clk-1(−)). As expected, full-length CLK-1 was able to rescue ubiquinone biosynthesis in these worms; however, CLK-1 nuc(+) could not (Fig. 3c ). This infers that, similar to nuclear COQ7 in human cells, nuclear CLK-1 does not contribute to the mitochondrial biosynthetic role of CLK-1 in worms.
Nuclear CLK-1 and COQ7 regulate ROS metabolism
It has been reported that clk-1 null worms have increased mitochondrial ROS and are more sensitive to high levels of oxidative stress 25, 26 . We therefore analysed the role of nuclear CLK-1 in modulating ROS responses. Expression of CLK-1 nuc(+) in clk-1 null worms partially rescued the increased ROS levels observed in these animals ( Fig. 4a ). CLK-1 nuc(+) was also able to significantly rescue the ROS-sensitivity phenotype of clk-1 null worms when exposed to the mitochondrial respiratory chain inhibitor Paraquat (Fig. 4b ). Importantly, in human cells lacking nuclear COQ7, we also observed increased basal and induced levels of ROS ( Fig. 4c ) and these cells exhibited increased sensitivity to ROS-induced cell death ( Fig. 4d ).
These results indicate that there is a conserved role for nuclear CLK-1 in the response of cells to ROS, potentially through regulation of ROS metabolism.
Mitochondrial glutamine metabolism is a key regulator of cellular redox balance and its inhibition is linked to increased ROS levels in cancer cells 27, 28 . We examined whether the expression of the mitochondrial form of glutaminase (GLNA-1 in worms/GLS2 in humans), which converts glutamine to glutamate, was regulated in a nuclear CLK-1-dependent manner. In clk-1 null worms, glna-1 transcript levels were decreased compared with wild-type animals, an effect that was rescued in the presence of CLK-1 nuc(+) ( Fig. 4e and Supplementary Fig. 3a ). Loss of nuclear COQ7 in human cells also resulted in a decrease in the expression of the glna-1 homologue GLS2 (Fig. 4g ,i and Supplementary Fig. 3d ). These data suggest that nuclear CLK-1 and COQ7 may regulate cellular ROS levels by promoting glutamine metabolism. Another regulator of ROS metabolism is the oxidoreductase WWOX, a hyperactivated form of which has been shown to increase cellular ROS levels in Drosophila melanogaster 29 . Interestingly, the transcript levels of one of the worm WWOX homologues are increased in clk-1 null worms 30 . We found that expression of CLK-1 nuc(+) could rescue the increased expression of the closest WWOX homologue, dhs-7, in clk-1 null worms, and that human WWOX expression was increased on loss of nuclear COQ7 ( Fig. 4f ,g,i and Supplementary Fig. 3a,d ). Taken together, these data suggest that nuclear CLK-1 and COQ7 can potentially regulate metabolic pathways that alter cellular ROS production independently of ubiquinone.
As cellular ROS levels were changed in a nuclear CLK-1dependent manner, we sought to determine whether ROS-dependent gene expression was also altered. We found that transcripts of sod-2, encoding a ROS detoxification enzyme, were increased in clk-1 null worms as previously reported 26 . Furthermore, transcripts of skn-1, encoding a transcription factor that is a central regulator of ROS homeostatic gene expression 31 , were also increased ( Supplementary Fig. 3b ). The expression of nuclear CLK-1 in clk-1 null worms abrogated the increased transcript levels of these genes ( Supplementary Fig. 3b ). Human homologues of sod-2 and skn-1, SOD2 and NRF2 respectively, and the NRF2 target gene HMOX1 were also increased in cells lacking nuclear COQ7 ( Fig. 4i and Supplementary Fig. 3c ). Our data indicate that the increased ROS levels observed in the absence of nuclear CLK-1 or COQ7 promote a ROS-defensive gene expression program. However, as the loss of nuclear CLK-1 or COQ7 sensitizes cells to oxidative stress ( Fig. 4b,d ) even in the presence of these increased ROS defences, it suggests that survival pathways may also be altered. To address this, we AFG3L2  TIMM22  ATG16L1  HSPA9  CLPP  HSPE1  CLPX  HSPD1  SPG7  LONP1  PMPCB  DNAJA3  YME1L1  ENDOG  DNAJB9 HSPA5
Relative expression
Relative expression examined the expression of the pro-apoptotic mitochondrial protease HTRA2, which is stimulated through a ROS-dependent retrograde pathway activated by disruption to mitochondrial proteostasis 32 . HTRA2 levels were significantly increased in cells lacking nuclear COQ7 (Fig. 4h,i and Supplementary Fig. 3d ) and the inhibition of HTRA2 activity rescued the ROS-sensitivity phenotype of these cells (Fig. 4j) . These data support a role for nuclear CLK-1 and COQ7 in regulating retrograde ROS responses through modulation of gene expression.
Mitochondrial and nuclear CLK-1 independently contribute to longevity
In addition to changes in ROS metabolism, C. elegans clk-1 null mutants and heterozygous mice have extended lifespans 17, 21 . C. elegans lacking CLK-1 survive by obtaining ubiquinone from their diet and heterozygous mice exhibit wild-type ubiquinone levels, suggesting that their increased longevity may be unrelated to the function of CLK-1 in ubiquinone biosynthesis 19, 21 . Interestingly, the expression of CLK-1 nuc(+) in clk-1 null worms caused a decrease in their enhanced longevity phenotype (Fig. 5a,b and Supplementary Table 1 ). This infers that nuclear CLK-1 can regulate longevity and that this is unrelated to the mitochondrial role of CLK-1 in ubiquinone biosynthesis. It also suggests that nuclear and mitochondrial CLK-1 regulate lifespan through distinct mechanisms. The expression of CLK-1 nuc(+) did not rescue the delayed larval development observed in clk-1 null worms 17 (Fig. 5c ), which is consistent with this phenotype being due to the loss of mitochondrial CLK-1.
Nuclear CLK-1 and COQ7 suppress the expression of a subset of UPR mt genes
The extended lifespans of clk-1 mutants, and other mitochondrial longevity phenotypes, have been linked to activation of a distinct mitochondrial to nuclear retrograde pathway, the mitochondrial unfolded protein response 11, 12 (UPR mt ). The UPR mt responds to mitochondrial dysfunction by regulating nuclear gene expression 13 and there is an increase in the expression of some UPR mt -responsive genes in clk-1 null worms 11, 30 . Thus, it is plausible that there could be crosstalk between CLK-1 nuclear signalling and the UPR mt . Indeed, we found that the expression of an UPR mt -responsive fluorescent reporter, which is activated in clk-1 null worms, was significantly reduced in the presence of CLK-1 nuc(+) (Fig. 6a ). This indicates that nuclear CLK-1 may potentially act as a suppressor of the UPR mt . We subsequently monitored transcript levels for a range of UPR mt genes 11, 33 and identified a subset (hsp-6, hsp-60, spg-7 ) where increased expression in clk-1 null worms was abrogated by expression of CLK-1 nuc(+) ( Fig. 6b and Supplementary Fig. 4a ). Importantly, this regulation of the UPR mt was conserved as the suppressed expression of homologues of these genes (HSPA9, HSPD1, AFG3L2) and of other UPR mt -associated genes (ATG16L1, CLPP, CLPX, HSPE1, LONP1, SPG7, TIMM22) was relieved on loss of nuclear COQ7 in human cells (Fig. 6c,d and Supplementary Fig. 4b ). The UPR mt can be activated by an imbalance between mitochondrial-and nuclear-encoded mitochondrial proteins 12 but this was not observed in cells lacking nuclear COQ7 ( Fig. 6d and Supplementary Fig. 4c ; compare MTCO1 to COXIV). Furthermore, we noted that some of the UPR mt -associated genes that were not regulated by nuclear COQ7 (DNAJA3, ENDOG, PMPCB, tim-17, ymel-1/YME1L1) are downstream targets of a distinct UPR mt instigated in the mitochondrial matrix 33 (Fig. 6b,c and Supplementary  Fig. 4a,b ). These data, therefore, demonstrate that nuclear CLK-1 and COQ7 can selectively suppress a branch of the UPR mt .
COQ7 associates with chromatin
As we have demonstrated that nuclear CLK-1 and COQ7 have a role in regulating gene expression, we investigated a possible direct association with chromatin and components of the gene expression machinery. We performed chromatin fractionation of cells expressing COQ7 or the non-nuclear R28A mutant and found that the uncleaved form of COQ7, but not the R28A mutant, was enriched in the chromatin fraction (Fig. 7a ). This suggests that nuclear COQ7 can associate directly with DNA-protein complexes. We next performed chromatin immunoprecipitation (ChIP) for endogenous COQ7 followed by promoter microarray (ChIP-on-chip) analysis. We uncovered a number of unique promoter sites enriched in COQ7 ChIPs compared with the IgG control ( Supplementary Table 2 ). Interestingly, we identified WWOX and TIMM22 as genes with sites enriched in the COQ7 ChIP ( Fig. 7b ) and whose expression is potentially regulated by nuclear COQ7 (Figs 4g and 6c ). To provide additional confirmation that these were COQ7 chromatinbinding sites, we performed ChIP followed by qPCR targeting these Most CLK-1 localizes to mitochondria by means of its mitochondrial targeting sequence (MTS), where it is required for the biosynthesis of ubiquinone (UQ), an essential cofactor in the electron transport chain (ETC). However, basal levels of ROS, produced by the mitochondria, direct a pool of CLK-1 to the nucleus where it regulates gene expression. Some CLK-1-regulated genes are directly involved in mitochondrial ROS metabolism and, therefore, the prolonged presence of CLK-1 in the nucleus lowers ROS levels. Reduced ROS leads to CLK-1 being predominantly localized to mitochondria, and not the nucleus, so its affects on gene expression are relieved, basal ROS production returns, and homeostasis is maintained. (b) Loss of nuclear COQ7 (R28A mutant) in human cells or loss of CLK-1 in worms (that scavenge UQ from their bacterial diet) alters ROS metabolism leading to increased ROS levels, augments the UPR mt , and extends the lifespan of worms. (c) The increased ROS levels, augmented UPR mt and extended lifespan in clk-1(−) worms were suppressed by expression of a nuclear-localized CLK-1 mutant (CLK-1 nuc(+) ) that acts to try to maintain mitochondrial homeostasis. sites. Cells expressing wild-type COQ7 exhibited an enhanced ChIP signal compared with those expressing the non-nuclear R28A mutant (Fig. 7c ). Furthermore, the ChIP signals for endogenous COQ7 at the WWOX and TIMM22 sites were decreased following treatment with the antioxidant NAC (Fig. 7d) , which would correlate with the decrease in the amount of nuclear COQ7 observed under such conditions (Fig. 1f) . These data establish that the nuclear pool of COQ7 can directly associate with chromatin and that this may contribute to its ability to regulate gene expression.
DISCUSSION
We have uncovered a conserved role for the respiratory enzyme CLK-1 as a direct mediator of mitochondrial to nuclear retrograde signalling that responds to changes in cellular oxidative status and regulates mitochondrial ROS metabolism, proteostasis and longevity ( Fig. 8 ). CLK-1 was previously assumed to modulate lifespan solely by acting in mitochondria. Indeed, clk-1 null worms have defective oxidative phosphorylation 34 and, similar to the many other respiration mutants that are long-lived 14 , this is likely to contribute to their increased lifespan. We have now established that a nuclear form of CLK-1 acts independently to limit longevity, suggesting that the mitochondrial and nuclear forms of the protein contribute to lifespan phenotypes through distinct mechanisms.
Our data suggest that the nuclear role of CLK-1 and COQ7 may be to regulate gene expression; however, the exact mechanism is unclear. COQ7 associates with a significant number of genomic loci but how it promotes or suppresses transcription remains to be elucidated. It will be important to determine whether the enzymatic activity of COQ7 plays a role or whether it is involved in the recruitment of other transcriptional regulators. There is precedent for mitochondrial enzymes associating with nuclear genes; the yeast enzyme Arg5,6 participates in arginine biosynthesis but also binds to nuclear targets and modulates transcription 35 .
The elevation of ROS signalling and activation of the UPR mt are reported to promote longevity 10, 12, 25, 36, 37 ; thus, the modulation of these pathways by nuclear CLK-1 would be consistent with its role in limiting lifespan. Our data suggest that nuclear CLK-1 and COQ7 function as a rheostat to maintain ROS homeostasis and dampen stress-responsive pathways such as the UPR mt . In such a model, basal levels of ROS, produced by mitochondria during normal functioning, direct a pool of CLK-1 to the nucleus where it regulates gene expression. Some CLK-1-regulated genes are directly involved in mitochondrial ROS metabolism and, therefore, the prolonged presence of CLK-1 in the nucleus could instigate a decrease in ROS production. Reduced ROS leads to CLK-1 being predominantly localized to mitochondria, and not the nucleus, so its effects on gene expression are relieved, basal ROS production returns, and homeostasis is maintained. Defining the specific tissues and conditions under which this nuclear cycling occurs in response to metabolic activity will be a key step to understanding the physiological role of CLK-1.
Nuclear CLK-1 suppresses the UPR mt , suggesting that it acts to prevent activation of this pathway during non-stress conditions (Fig. 6 ). Increases in mitochondrial ROS production promote nuclear CLK-1 localization, thus maintaining ROS homeostasis but also limiting activation of the UPR mt . The UPR mt offers protection following the accumulation of unfolded or misfolded proteins in mitochondria, but it is not clear whether it plays a significant role in the cellular response to oxidative stress. Indeed, it has been reported that activation of the UPR mt does not confer resistance to worms subjected to high levels of a mitochondrial ROS stress 11 .
Our study provides the first example of a mitochondrial respiratory enzyme where two distinct forms from the same translation product are targeted to separate organelles, with the mitochondrial form participating in oxidative phosphorylation and the nuclear form acting as a sensor of metabolic activity through regulating gene expression. Dual targeting of metabolic enzymes to mitochondria and other organelles may be a common theme in cells 38 and examples of mitochondrial enzymes having nuclear roles have been reported 35, [39] [40] [41] . One example is the pyruvate dehydrogenase complex (PDC) that has been shown to translocate from mitochondria to the nucleus in response to growth factor stimulation and respiratory chain inhibition. There, it facilitates acetyl-CoA synthesis and promotes histone acetylation 41 . Interestingly, in contrast to CLK-1, PDC is proposed to translocate to the nucleus from the mitochondrial matrix as an intact complex following the mitochondrial import and cleavage of the N-terminal MTS domains of the individual subunits. In worms, the transcription factor ATFS-1 also localizes to both organelles but, unlike CLK-1, translocates only to the nucleus during times of mitochondrial stress when normal proteostasis is disrupted. In the absence of stress, it is degraded following mitochondrial import 11 .
It will be of interest to determine whether redirection from mitochondria to nuclei represents a paradigm for other proteins in maintaining homeostasis during mitochondrial activity or dysfunction. This study contributes to our understanding of the fundamental signalling processes that mediate the response of cells and organisms to changes in respiratory activity that occur during ageing and in disease.
METHODS
Methods and any associated references are available in the online version of the paper. siRNA. Knockdown of endogenous COQ7 transcripts was performed using a pool of siRNAs against 5 -UTR: 5 -AGCAACCACUUCGUUGAACUU-3 and 5 -ACU UCGUUGAACGGAACUGUU-3 ; and 3 -UTR: 5 -ACCUGUUUCUCUGCAAA UGUU-3 . siRNAs were designed using the siRNA design tool from the Whitehead Institute for Biomedical Research and ordered from Eurofins Genomics.
Cell culture, transfections and stable cell lines. HeLa, COS7 and HEK293 cells
were obtained from ATCC and maintained in Dulbecco's modified Eagle's medium supplemented with 5 mM glutamine, 100 units ml −1 penicillin/streptomycin, and 10% fetal bovine serum (Life Technologies). Plasmid DNA transfections were performed with jetPEI (Polyplus) and siRNA transfections with Lipofectamine RNAiMAX (Life Technologies). HEK293 stable cell lines were selected with 1 mg ml −1 G418 (Sigma) following transfection with pcDNA3.1-COQ7 or pcDNA3.1-COQ7(R28A), before monoclonal isolation and expansion. Hydrogen peroxide (Sigma), tert-butyl hydroperoxide (Luperox TBH70X, Sigma), and cobalt (II) chloride hexahydrate (Sigma) were diluted in water before use; HTRA2 inhibitor, UCF-101 (Calbiochem), was resuspended in DMSO.
Antibody generation and purification. COQ7 antibodies were raised in rabbits using bacterially expressed GST-COQ7 as an immunogen. Rabbits were immunized and serum was collected off-site (Genscript) and antibodies were purified against the N terminus, essentially as described previously 42 . Briefly, bacterially expressed GST or GST-COQ7(1-37) bound to GSH-Sepharose were washed twice in 0.2 M borate pH 8.6 before incubation in 20 mM dimethyl pimelimidate in 0.2 M triethanolamine pH 8.3 for 30 min to crosslink the proteins to the resin. Crosslinking was terminated by addition of 0.2 M ethanolamine pH 8.2 for 1 h before two washes in 0.1 M glycine pH 2.5 to remove non-covalently linked molecules before equilibration in TBS (15 mM Tris-HCl pH 7.4, 150 mM NaCl). Antibodies to be purified were adjusted to ×1 TBS before incubation with GSH-GST crosslinked resin for 4 h and GST-specific antibodies were removed by centrifugation. The supernatant was added to GSH-GST-COQ7(1-37) crosslinked resin, incubated for 18 h and washed. COQ7(1-37)-specific antibodies (COQ7 N-term2 ) were eluted with 0.1 M glycine pH 2.5 before pH adjustment to neutral with 2 M Tris. COQ N-term anti-COQ7(1-37)specific antibodies were derived using the same protocol but starting with anti-COQ7 (Santa Cruz, sc-135040). For COQ7 FL antibodies used in ChIP experiments, GST-cleared supernatants were incubated with GSH-GST-COQ7 (full length) before glycine elution.
Antibodies. The following antibodies were used for protein identification: antic-Jun (JUN, Santa Cruz, sc-1694, western blot (WB) 1:500); anti-CLPP (Santa Cruz, sc-134496, WB 1:500); anti-COQ7 (Proteintech, 15083-1-AP, WB 1:2,000, immunofluorescence (IF) 1:500); anti-COXIV (Pierce, MA5-15078, WB: 1:2,000); anti-FLAG (M2, Sigma, F1804, IF 1:500); anti-GLS2 (Abcam, ab113509, WB 1:500); anti-HSPA9 (Grp75/mtHsp70, Cell Signaling, 2816S, WB 1:1,000); anti-HSPD1 (HSP60, BD Transduction Laboratories, 611562, WB 1:2,000); anti-HTRA2 (OMI, Biovision, 3497-100, WB 1:1,000); anti-lamin B1 (LMNB1, Santa Cruz, sc-6216, WB 1:2,000); anti-MTCO1 (1D6E1A8, Life Technologies, 459600, WB 1:2,000); anti-Myc (4A6, Millipore, 05-742, WB 1:2,000, IF 1:500); anti-NRF2 (NFE2L2, Santa Cruz, sc-722, WB 1:500); anti-WWOX (Cell Signaling, 4045, WB 1:500); anti-OLLAS (Novus Biologicals, NBP1-06713, WB 1:500 and Genscript, A01658, IF 1:200); anti-tubulin β (TUBB, Abcam, ab6046, WB 1:5,000).
Immunofluorescence, microscopy and image analysis. Cells for microscopy
were grown on coverslips, fixed in 4% paraformaldehyde (PFA, Sigma) for 10 min and then permeabilized in 0.2% Triton X-100 for 10 min. All steps were performed in ×1 PBS (phosphate buffered saline, Fisher). For immunofluorescence, cells were blocked in 3% bovine serum albumin (BSA) for 1 h, incubated in primary antibody in 3% BSA for 18 h, washed, incubated in Alexa Fluor-conjugated secondary antibody (1:1,000; Life Technologies) in 3% BSA for 1 h, and washed again. Coverslips were mounted in ProLong Gold with DAPI (Life Technologies). For MitoTracker (MitoTracker Red CMXRos; Life Technologies) staining, the dye was applied at 10 µM to media 30 min before cell fixation. For endogenous COQ7 immunofluorescence, cells were fixed in PFA for 5 min and permeabilized in methanol at 20 • C for 2 min, and then 0.2% Triton X-100 for 5 min. Images were collected on an Olympus BX51 upright microscope using a ×60 objective and captured using a Coolsnap ES camera (Photometrics) through MetaVue software (Molecular Devices). Images shown in Figs 1a,d,j and 2a,c and Supplementary  Fig. 1b ,c are representative of 3 independent experiments. Figure 1b is representative of the analysis in Supplementary Fig. 1a .
Western blotting. Western blotting was performed essentially as described previously 43 . Briefly, cell lysates, unless for fractionations, were prepared in Triton lysis buffer (TLB: 20 mM Tris-HCl pH 7.4, 150 mM NaCl, 25 mM βglycerophosphate, 2 mM sodium pyrophosphate, 2 mM EDTA, 1% Triton X-100, 10% glycerol plus protease inhibitors). Samples were resolved by SDS-PAGE (10-13% gels) and transferred to Immobilon-P membranes (Millipore), which were then immunoblotted. Primary antibodies were detected with IRDye 800CW or IRDye 680LT secondary antibodies (1:5,000; LI-COR) using the Odyssey imaging system or HRP-conjugated secondary antibodies (Amersham Biosciences), followed by enhanced chemiluminescence (Pierce). Densitometry was performed using ImageJ. Supplementary Figs 3d and 4c , respectively.
Mitochondrial isolation.
Mitochondrial isolation was performed essentially as described previously 44 . Briefly, cell pellets were resuspended in hypotonic buffer (10 mM Tris-HCl pH 7.4, 0.1 mM EDTA, 250 mM sucrose) and left on ice to swell for 10 min. Cells were homogenized on ice with 50 strokes of a Dounce homogenizer before centrifugation at 500g for 5 min to pellet the nuclear fraction. The supernatant was transferred to a new tube and centrifuged again at 10,000g for 20 min to pellet mitochondria.
Cell survival and proliferation assays. Cell survival was measured by MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, Sigma) assay. MTT (5 mg ml −1 ) was added to cells 4 h before experimental end points after which cells were washed and intracellular formazan (reduced MTT) solvated with 0.4 M HCl in 99% propanol for 1 h. The amount of formazan was assayed using a microplate reader spectrophotometer at A 570 nm . Cell death was measured by lactose dehydrogenase presence in media, released from apoptotic or necrotic cells, using the CytoTox 96 Non-Radioactive Cytotoxicity Assay (Promega), following the manufacturer's instructions. MTT activity in the absence of detectable cell death was considered as proliferation.
Cellular ROS measurements. Intracellular ROS levels were determined by incubating cells with 10 µM 2 ,7 -dichlorofluorescein diacetate (DCFDA, Life Technologies) for 30 min before cells being washed, lysed in TLB and centrifuged at 20,000g for 10 min. DCF fluorescence was measured in triplicate from supernatants using a microplate reader spectrophotometer at excitation 485 nm and emission 520 nm.
RNA isolation and quantitative reverse transcription PCR. RNA was isolated from cells using the RNeasy system (Qiagen) following the manufacturer's instructions. Contaminating DNA was removed using the DNA-free Kit (Life Technologies). Quantitative reverse transcription PCR analysis was performed for both HEK293 cells and worm samples using the Power SYBR green RNA-to-CT 1-
Step Kit (Life Technologies) following the manufacturer's instructions, with 10 µl reactions. Each experimental repeat was run in triplicate. Primer sequences can be found in Supplementary Table 3 . References for primer sequences are available on request. Reference genes for quantification: human, RPL19; C. elegans, act-1 and tba-1. Changes in gene expression were quantified using the ∆∆Ct method 45 , normalizing for each gene to the reference gene for the same sample and then to one control sample, as indicated in the figure legends. The heat map in Fig. 6c was generated using Multi Experiment Viewer software and represents the mean values of four independent experimental repeats ( Supplementary Fig. 4b ).
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Quinone extraction and reverse-phase high-performance liquid chromatography. Quinone extraction and determination was performed essentially as described previously 46 . Briefly, cell or worms pellets that had been frozen and thawed three times were resuspended in lysis buffer (15 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.1% SDS) and vortexed. Quinones were extracted by vortexing resuspended pellets in ethanol/hexane (2/5, v/v) for 10 min followed by centrifugation at 20,000g for 5 min and the top hexane supernatant layer was removed. This was repeated three times and the supernatants were combined. Hexane was removed by drying in a SpeedVac Concentrator and the residue was resuspended in ethanol. Resuspended quinones were applied to a reverse-phase column (Jupiter 4 µm Proteo 90 Å, C-12, 250 × 4.6 mm, Phenomenex) and eluted in isocratic conditions (1 ml min −1 , diisopropyl ether/methanol (1/4, v/v)) by highperformance liquid chromatography (Ettan LC, GE Healthcare). Eluted quinones were compared using their retention times and ultraviolet spectrophotometry (A 275 nm ). Ubiquinone-10 (Coenzyme Q10, Sigma) and ubiquinone-9 (Sigma) were used as standards for human and C. elegans endogenous ubiquinone, respectively. Clioquinol (Vetranal, Sigma) was used to inhibit COQ7 activity 47 Chromatin fractionation. Isolation of chromatin/DNA-associated protein complexes from cells was performed essentially as described previously 48 . Briefly, cells were washed then scraped in CSK buffer (10 mM PIPES pH 6.8, 300 mM sucrose, 100 mM NaCl, 3 mM magnesium chloride, 1 mM EGTA, 0.5% Triton X-100 plus protease inhibitors) and left at 4 • C for 5 min before centrifugation at 5,000g for 3 min. The supernatant was removed as the Triton-soluble fraction. The pellet was resuspended in CSK buffer containing 30 U DNase I (New England Biolabs) and incubated at 37 • C for 20 min followed by precipitation of chromatin by addition of 0.25 M ammonium sulphate and incubation at 4 • C for 5 min. Samples were then centrifuged at 5,000g for 3 min and the supernatant was taken as the DNase-soluble fraction.
Chromatin immunoprecipitation. Chromatin immunoprecipitations (ChIPs) for qPCR analysis of promoter regions or promoter microarray were carried out essentially as described previously 49 . Cells were washed then crosslinked in 0.85% formaldehyde for 10 min at 20 • C before quenching with a final concentration of 0.125 M glycine for 5 min. Cells were then washed and lysed in FA buffer (50 mM Tris pH 8, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS, protease inhibitors) for 10 min at 4 • C followed by sonication using a 4 • C water bath sonicator (Bioruptor Sonicator, Diagenode) set to medium power with cycles of 30 s on 30 s off for 5 min or until an average DNA fragment length of 0.3-0.7 kb was obtained. Samples were centrifuged at 21,000g for 10 min before addition of ABRI buffer (50 mM Tris pH 8,150 mM NaCl, 1 mM EDTA, 0.5% NP-40, 0.5% sodium deoxycholate, protease inhibitors) 3:1 to supernatants. A 1/20 fraction of each sample was taken as input and the rest was used for immunoprecipitations. Two micrograms of each antibody (COQ7 FL or rabbit IgG control, Santa Cruz, sc-2027) was added before rotation for 18 h at 4 • C and addition of 15 µl pre-washed protein A Dynabeads (Life Technologies) for a further 1 h. ChIPed complexes were washed once in ABRI buffer, twice in WB1 buffer (20 mM Tris pH 8, 2 mM EDTA, 150 mM NaCl, 1% Triton X-100), twice in WB2 buffer (20 mM Tris pH 8, 2 mM EDTA, 250 mM LiCl, 0.5% NP-40, 0.5% sodium deoxycholate), and once in TE buffer (25 mM Tris, 1 mM EDTA) before elution in 1% SDS and 0.1 M NaCHO 3 with rotation/shaking at 30 • C for 30 min. Eluted complexes and inputs were then adjusted to 150 mM NaCl and crosslinks were reversed by incubation at 65 • C for 18 h. Samples were then treated with proteinase K (Sigma) for 2 h at 50 • C. ChIPed and input DNA was then phenol/chloroform/IAA (Sigma) purified and washed before final solvation in TE buffer. For qPCR analysis of promoter enrichment, primers against regions of interest ( Supplementary Table 3 ) were used to amplify DNA in both ChIPs and inputs and antibody enrichment calculated as a percentage of input using the following formulae: 2 X = input dilution factor, total input Ct value = input Ct-X, sample percentage of input = 2 (total input Ct−sample Ct) × 100. For promoter microarray analysis, DNA samples for IgG control or COQ7 ChIPs were amplified using random-primer PCR amplification. DNA was subjected to two rounds of PCR. Initial reactions of 40 ng DNA, ×1 Sequenase buffer (US Biochemical) and 5 µM of the degenerate primer 5 -GTTTCCCAGTCACGATCNNNNNNNNN-3 were subjected to two cycles of primer extension: 98 • C for 5 min, 8 • C for 4 min, slow ramped (10%) from 8 to 37 • C before a further 8 min at 37 • C. During the first 8 • C hold the reaction mixture was adjusted to 0.25 mM dNTPs, 3 mM dithiothreitol and 0.05 mg ml −1 BSA; during the second 8 • C hold 1.5 U µl −1 Sequenase (US Biochemical) was added. DNA was purified with a PCR Clean-up Kit (Qiagen) and all eluted DNA was then subjected to a second round of PCR with 1 U µl −1 Biotaq polymerase (Gentaur), 0.25 mM dNTPs, ×1 Biotaq buffer and 1 µM of the amplification primer 5 -GTTTCCCAGTCACGATC-3 denatured at 97 • C for 3 min before 25 cycles of: 97 • C for 30 s, 40 • C for 10 s, 50 • C for 30 s and 72 • C for 90 s; followed by a final extension of 72 • C for 5 min. Amplified DNA was again purified as before and 10 µg of each sample was sent for processing at the on-site genomic technologies facility using Affymetrix GeneChip Human Promoter 1.0R Arrays. Enriched probe sets were analysed for two repeats of the experiment and regions significantly enriched in COQ7 ChIPs compared with IgG control are listed in Supplementary Table 2. C. elegans strains. C. elegans were cultured at 20 • C on nematode growth medium (NGM) agar plates seeded with OP50 strain Escherichia coli 50 . The following strains were obtained from the Caenorhabditis Genetics Center: SJ4100 zcIs13 
Generation of C. elegans transgenic strains. Transgenic strains OL0092
and OL0119 were generated using MosI-mediated single copy insertion (MosSCI) as described previously 51 . Briefly, a plasmid containing pclk-1::clk-1::gfp was generated using Gateway techniques (Invitrogen). pDONR clones were generated for the clk-1 promoter and open reading frame using Gateway and gene-specific primers. The vector pJA256 (ref. 52) was used as the pDONR clone for GFP. The final destination vector used was pCFJ150, which contains an unc-119 rescue fragment. pclk-1::clk-1 ∆MTS (13-187)::gfp was generated by mutagenesis of the pclk-1::clk-1::gfp plasmid. Primer sequences are available on request. MosSCI was performed using the direct injection protocol. unc-119 animals were injected with an injection mix consisting of: pCFJ150 containing pclk-1::clk-1::gfp or pclk-1::clk-1 ∆MTS (13-187)::gfp (50 ng µl −1 ), pCFJ601 (50 ng µl −1 ), pMA122 (10 ng µl −1 ), pGH8 (10 ng µl −1 ), pCFJ90 (2.5 ng µl −1 ) and pCFJ104 (5 ng µl −1 ). Selection was based on heat shock survival, wild-type movement, no expression of mCherry markers and GFP expression. Insertion of the transgene was confirmed by sequencing.
Worm imaging. MitoTracker staining was performed as follows. Approximately 2-3-day-old adult worms were washed off NGM agar plates using M9 buffer. Worms were washed twice in M9 buffer, and then once in MR buffer (10 µM MitoTracker Red CMXRos (Invitrogen) in M9 buffer), before being incubated in MR buffer for 2 h on a rotating mixer at room temperature in the dark. The worms were then pelleted before being washed once with M9 buffer and being allowed to recover on a standard NGM agar plate for 1 h at 20 • C. They were then mounted on agarose pads and imaged at ×100 magnification on a Leica DM5000B fluorescence microscope and images were captured by a Leica DFC340FX camera. Cells in the tail region were imaged. For NAC experiments, synchronized clk-1::gfp; his-24::mcherry worms were grown on untreated NGM agar plates or plates containing 10 mM NAC. Adult worms were imaged as described and the proportion of nuclear CLK-1-GFP was determined by co-localization with the HIS-24-mCherry nuclear marker. For hsp-6::gfp reporter assays, between 40 and 60 young adult worms were mounted on agarose pads as described and imaged at ×5 magnification. Fluorescence intensity was quantified using ImageJ. Images shown in Figs 1c and 3b are representative of >6 independent experiments. Measurement of worm ROS levels. ROS were measured using dihydroethidium (DHE). Briefly, synchronized adult worms were washed 3 times in PBS and then incubated in 3 µM DHE for 30 min. Following incubation worms were washed in PBS and then mounted on agarose pads and imaged at ×63 magnification. The fluorescence intensity in the head of the worm was quantified using ImageJ.
Paraquat sensitivity assay. Synchronized adult worms were treated with 40 mM Paraquat, dissolved in M9 buffer, for 6 h in a 96-well plate. Approximately 25 worms were plated in each well, with each strain measured in triplicate. Survival was measured every 2 h with worms being scored as dead if they failed to respond to gentle tapping of the plate.
Lifespan assays. Lifespan assays were performed as described previously 53 . Briefly, 100 synchronized L1 stage worms were plated onto standard NGM agar plates seeded with OP50 bacteria. On reaching adulthood worms were transferred daily to fresh plates until egg laying ceased. Worms were scored daily, being judged as dead when they failed to respond to gentle prodding from a worm pick. Any worms that crawled off the plates during the assay were censored. Presented lifespan plots are representative of lifespan from the L1 larval stage from 3 independent experiments. The full analysis is presented in Supplementary Table 1 . The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. No statistical methods were used to predetermine sample size. Development assays. Gravid adult worms were bleached and the embryos plated on NGM agar plates without food overnight. Synchronized L1 worms were transferred to spotted NGM plates and larval stage was determined every 24 h until all of the worms reached adulthood. Approximately 50 worms per time point for each genotype were mounted on agarose pads and scored then discarded.
Worm RNA extraction. Synchronized day 1 adult worms were pelleted and vortexed in 250 µl Trizol (Life Technologies) for 2 min and left for 30 min to dissolve. Fifty microlitres of chloroform was added and tubes were vortexed for 2 min before centrifugation at 20,000g for 5 min. The supernatant was removed to a new tube and 125 µl of propanol was added for 30 min before centrifugation at 20,000g for 5 min. The supernatant was discarded and the pellet was dissolved in RNase-free water. Contaminating DNA was removed using the DNA-free Kit (Life Technologies).
Statistical analysis.
Values are expressed as mean; error bars represent the standard error of the mean. Data were analysed, unless otherwise stated, using unpaired Student's t-test and confidence is given by the P values indicated in the figure legends. For analysis of the proportion of cells with nuclear staining ( Supplementary  Fig. 1a ) a z-test was used. For lifespan assays, survival time was estimated with the Kaplan-Meier method and the log-rank method was applied to compare survival curves. Fig. 1b. (b) The region of COQ7 required for specific nuclear localisation resides between amino acids 11 and 29. GFP fluorescence of COS7 cells expressing GFP-COQ7 and the deletion mutants GFP-COQ7(11-217), lacking amino acids 1-10, and GFP-COQ7(30-217), lacking amino acids 1-29. Orientating the GFP tag on the N-terminus of COQ7 abolished mitochondrial localisation and promoted nuclear localisation, probably due to disruption of the interaction between the N-terminal MTS and the mitochondrial import machinery. Mitochondria are stained with MitoTracker (MT) and nuclei with DAPI. Schematic depicts the GFP-COQ7 deletion mutants used and summarises their localisation. (c) Endogenous uncleaved COQ7 is nuclear. HeLa cells immunostained with a second antibody specific to the N-terminus of COQ7 (COQ7 N-term2 ). Nuclei are stained with DAPI. (d) Immunoblot demonstrating that uncleaved wild type COQ7 (WT) migrates at the same position as COQ7 S36A (containing a point mutation in the predicted mitochondrial processing peptidase cleavage site) and that cleaved COQ7 migrates at the same position as COQ7 (37- 
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